RUN filing: 21,037 vested shares to be sold on NASDAQ Oct 9, 2025

Rhea-AI Filing Summary

Sunrun Inc. insider notice reports a proposed sale of 21,037 common shares, with an aggregate market value of $425,999, representing a small fraction of the 230,732,572 shares outstanding. The sale is planned for 10/09/2025 on NASDAQ.

The reported shares were acquired through equity compensation: 1,477 shares from a performance stock lapse on 03/01/2025, 2,709 shares from restricted stock lapse on 03/06/2025, and 16,851 shares from restricted stock lapse on 04/06/2025. The filer also disclosed six open-market sales in the prior three months totaling 52,319 shares for gross proceeds of $937,094.

Positive

• 21,037 shares proposed for sale are clearly documented with acquisition dates and nature (equity compensation)
• Filer disclosed past 3-month sales totaling 52,319 shares with gross proceeds $937,094, improving transparency

Negative

• Multiple open-market sales in the prior three months—52,319 shares—could indicate continued insider selling pressure
• Proposed sale value $425,999 is a near-term dilution of insider-held shares available to market

Insights

Compliance Officer

TL;DR: Insider sale follows equity vesting and appears disclosed under Rule 144 with recent activity in prior months.

The notice identifies a proposed sale of 21,037 shares on 10/09/2025 under Rule 144, with the securities acquired via equity compensation on 03/01/2025, 03/06/2025, and 04/06/2025. The filing includes a standard representation that the signer has no undisclosed material adverse information.

Key compliance dependencies include adherence to Rule 144 volume and public information conditions and any applicable company trading policies. Watch near-term execution on 10/09/2025 and whether the seller uses a broker (listed as Charles Schwab & Co., Inc.) which can affect timing and reporting.

Equity Compensation Analyst

TL;DR: The shares proposed for sale equal recently vested equity from multiple lapses, totaling 21,037 shares.

The acquired shares stem from a mixture of a performance-stock lapse and restricted-stock lapses between 03/01/2025 and 04/06/2025, indicating routine post-vesting liquidity rather than an open-market purchase. The filing shows the total acquired amount equals the amount proposed for sale, suggesting the holder may be liquidating recent vesting events.

Monitor upcoming reported sale execution on 10/09/2025 and compare to recent sales of 52,319 shares in the past three months (gross proceeds $937,094) to assess whether this is part of an ongoing liquidation pattern over the near term.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	21037	425999.00	230732572	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Performance Stock Lapse	Sunrun Inc.			1477	03/01/2025	Equity Compensation
Common	03/06/2025	Restricted Stock Lapse	Sunrun Inc.			2709	03/06/2025	Equity Compensation
Common	04/06/2025	Restricted Stock Lapse	Sunrun Inc.			16851	04/06/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEANNA STEELE 600 California Street, Suite 1800 San Francisco CA 94108	Sunrun Inc.	08/18/2025	17417	283026.00
JEANNA STEELE 600 California Street, Suite 1800 San Francisco CA 94108	Sunrun Inc.	08/26/2025	7077	118540.00
JEANNA STEELE 600 California Street, Suite 1800 San Francisco CA 94108	Sunrun Inc.	09/08/2025	1433	24263.00
JEANNA STEELE 600 California Street, Suite 1800 San Francisco CA 94108	Sunrun Inc.	10/01/2025	20426	395248.00
JEANNA STEELE 600 California Street, Suite 1800 San Francisco CA 94108	Sunrun Inc.	10/06/2025	4440	85878.00
JEANNA STEELE 600 California Street, Suite 1800 San Francisco CA 94108	Sunrun Inc.	10/08/2025	1526	30139.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the Sunrun (RUN) Form 144?

A proposed sale of 21,037 Sunrun common shares valued at $425,999, planned for 10/09/2025 on NASDAQ.

How were the 21,037 RUN shares acquired?

All 21,037 shares were acquired via equity compensation: performance stock lapse on 03/01/2025 and restricted stock lapses on 03/06/2025 and 04/06/2025.

Did the filer sell other RUN shares recently?

Yes, the filer reported six sales in the prior three months totaling 52,319 shares for gross proceeds of $937,094 (sales dated between 08/18/2025 and 10/08/2025).

Which broker is handling the proposed sale for RUN shares?

The broker named in the filing is Charles Schwab & Co., Inc. (address listed).

What fraction of Sunrun's shares outstanding does this proposed sale represent?

The proposed 21,037 shares are out of 230,732,572 shares outstanding, representing a very small fraction of total shares.